Retail Cannabis Turning into the Next Investment Boom

VANCOUVER, BC / ACCESSWIRE / March 26, 2019 / Retailers are racing to take advantage of an explosive CBD market.

Neiman Marcus is pushing ahead with CBD sales at some of its stores and online. Simon Property Group is partnering with Green Growth Brands to open 108 stores in its malls just in 2019. Barney's will launch "The High End."

Now, one of the largest drugstores in the U.S. is selling cannabis products, too. CVS will now carry a line of CBD products in eight states, including California, Illinois, and Colorado.

In fact, the drug chain will now sell CBD creams, sprays, and lotions in those states.

"We are carrying hemp-derived CBD products in select states to help meet consumer demand for alternative care options," said CVS Health Spokesperson, Mike DeAngelis.

Along the way, it's creating a sizable sales opportunity for several companies, including The Yield Growth Corporation (CSE: BOSS)(OTCQB: BOSQF), Curaleaf Holdings Inc. (CURA)(CURLF), and Green Thumb Industries Inc. (GTII)(GTBIF).

The Yield Growth Corporation (BOSS)(BOSQF) just announced that Mad Wallaby Distribution Inc. as a new, wholly owned subsidiary which has been submitted for incorporation in the State of California. Mad Wallaby establishes legal U.S. retail and e-commerce distribution for beauty, health and wellness brands with products containing hemp ingredients including cannabidiol from hemp (CBD) that have less than 0.3 percent concentrations of THC.

"Establishing Mad Wallaby to create U.S. distribution channels for CBD products is an exciting, natural step for Yield Growth," says Penny Green, Yield Growth CEO, "As we are seeing now with the American national drugstore chain CVS for example, shelf space for these products is expanding quickly in relation to strong consumer interest and increasing market demand. Adherence to the complex and evolving laws surrounding these products remains important and represents our trusted distinction as a distributing partner for both emerging brands and the established retailers they seek to supply."

Mad Wallaby plans to build a distribution portfolio of 10 brands, including Yield Growth's own Urban Juve and a Mad Wallaby CBD product line in development- that meet its standards for quality and the legal requirements for products containing hemp pursuant to the U.S. Farm Bill and other applicable regulations.

For More Information on The Yield Growth Corporation (BOSS), Click Here.

Curaleaf Holdings Inc. (CURA)(CURLF) just announced that CVS will carry its line of CBD products. "We've been having dialogue with national retailers for many months now," Curaleaf CEO Joseph Lusardi said, as quoted by Bloomberg. "All large retailers are figuring out their hemp strategy and will address that in 2019 because there is such a huge product demand."

In addition, in its most recent quarter, the company reported that revenue rose 407% to $32 million from $6.3 million year over year. However, the company did post a fourth quarter loss of $16.5 million, or four cents per share as compared to a year-earlier profit of $624,000, or zero cents per share.

For More Information on Curaleaf Holdings Inc., Click Here.

Green Thumb Industries Inc. (GTII)(GTBIF) is a vertically integrated company that manufactures and sells a well-rounded suite of branded cannabis products including flower, concentrates, edibles, and topicals.

It also owns and operates a national chain of retail cannabis stores called RISE dispensaries. The company just acquired the For Success Holding Company, the Los Angeles-based creator of the lifestyle suite of Beboe branded cannabis products. Beboe is currently available in more than 125 retail locations in California and Colorado and via home delivery across California.

For More Information on Green Thumb Industries Inc., Click Here.

Legal Disclaimer / Nothing in this article should be considered as personalized financial advice. We are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial advisor before making any investment decision. This is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this article is not provided to any individual with a view toward their individual circumstances. Baystreet.ca has been paid a fee of four thousand five hundred dollars for The Yield Growth Corp. advertising. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. Because of this conflict, individuals are strongly encouraged to not use this article as the basis for any investment decision. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in this article is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between any predictions and actual results. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.

CONTACT:

Aaron Bodnar
aaron@baystreet.ca

SOURCE: Baystreet.ca Media Corp.

View source version on accesswire.com:
https://www.accesswire.com/540151/Retail-Cannabis-Turning-into-the-Next-Investment-Boom